The global oligonucleotide API market is poised to grow from USD 2.81 billion in 2024 to USD 4.84 billion by 2034, expanding at a CAGR of 5.60%. The increasing need for innovative drug classes and ...

(MENAFN- Meridian Market Consultants) The Reports and Insights, a leading market research company, has recently releases report titled “Oligonucleotide Active Pharmaceutical Ingredient (API) Market: ...

Each step within the company’s oligonucleotide manufacturing process uses unique, innovative equipment to deliver the highest-quality products and to increase sustainability. To ensure only the ...

NEWARK, Del., April 28, 2022 (GLOBE NEWSWIRE) -- According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 2.46 Bn in 2022, and ...

Bachem is one of key players and well-established companies operating in the Oligo CDMO market. The company is mainly focused on commercial manufacturing of oligonucleotide API and is expected to grow ...